Gland Pharma Shareholding Pattern | Q2-Sep Report 2024 | Shareholders Latest Updates

Gland Pharma Shareholding Pattern | Q2-Sep Report 2024 | Shareholders Latest Updates
Gland Pharma has released its latest shareholding reports, covering the Second quarter and the fiscal year ending on September 30 2024. This detailed report examines who owns shares, including Promoters, promoter groups, Foreign investors, public investors, and government entities.The percentage of shares held by the public decreased from 8.46% in June 2024 to 8.33% in September 2024.This reduction indicates that the publics stake in the company diminished during this period.DIIs (Domestic Institutional Investors) shareholding increased from 32.83% in June 2024 to 35.37% in September 2024 , indicating that domestic institutions increased their stake in the company by 2.54% . FIIs (Foreign Institutional Investors) shareholding decreased from 6.88% in June 2024 to 4.47% in September 2024 ,indicating that foreign institutions reduced their investments by -2.41 in the company during the quarter.This suggests a pullback in their investment.

Follow us on:
Instagram:   / stock_trade_updates  
Twitter:   / _stock_trade  
Facebook:   / 61557923535211  
Telegram Channel: https://t.me/+wKTzQjOCWs5lOTg1
Please Like Share and Subscribe

#Shareholding #Shareholders #StockOwnership #InvestmentPortfolio #EquityInvesting #StockMarketInvesting #InvestorRelations #Stockholders #OwnershipStructure #CorporateGovernance #InvestorUpdates #StockMarketTips #ShareholderMeeting #InvestmentStrategy #EquityShares

shareholding data stocks
share market stock screener
share market watchlist
share market stock analysis app
share market statement
stock market data provider
how to see stock prices
data stocks
stock analysis on nse
share market data provider